Antacid Medications Market Overview 2020, Global Size, Industry Growth, Share, Future Trends, Merger, Competitive Landscape, Top Company Profile, Regional Revenue, Technology Advancement
Antacid Medications Market Overview
Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion. Treatment with antacids is symptomatic and is usually recommended for minor symptoms. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids with magnesium may cause diarrhea, while those containing calcium and aluminum may cause constipation. Long-term use may cause kidney stones and may increase the risk of contracting osteoporosis. Popular antacid brands include Alka seltzer, Gelusil, Milk of Magnesia, Maalox, Gaviscon, Mylanta, Rolaids, and Tums.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/91
Distribution channel of Antacids
Antacids are mainly sold through two distribution channels, namely chemists and non-chemist. Non-chemists comprise grocers, general stores, and food stores. Abbott’s Digene and Pfizer’s Gelusil have a doctor heritage. Eno and Pudin Hara have an ayurvedic base and are available over the counter and are aiding in growth of the antacid medications market. Over-the-counter availability of antacids have enabled individuals to self-medicate their bouts of acid reflux, which can increase probability of suffering from stroke in the future. Antacids are available in different forms such as water dissolving tablet, powder form, and melt-in-mouth granules.
Antacid medications market taxonomy – Formulation, Drug and Demographic
Antacid medications market is classified by various ways such as by formulation, drug and Demographic. On the basis of formulation, the antacid medications market is classified as tablets, capsules, suspensions, and drops. On the basis of demographic, antacid medications market is classified as products for pediatrics and products for adults. On the basis of drug, antacid medications market is classified as histamine-2 (H2) blockers, proton pump inhibitor, and pro-motility agents. Examples of H2 blocker include Nizatidine, Ranitidine, Cimetidine, and famotidine. Proton pump inhibitors used for acid reflux include Rabeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Omeprazole. Pro-motility agents stimulate the muscles of gastrointestinal tract and strengthen lower esophageal sphincter, and reduce reflux into esophagus. Metoclopramide is used to treat heartburn associated with GERD.
Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/ongoing-insight/antacid-medications-market-91
Increasing incidence of acid reflux in North America fueling growth of the antacid medications market
Increasing trend of self-medication consequently fuels demand for OTC digestive products for treatment of gastrointestinal distress. Antacids are used to neutralize acidity and thus, are expected to lead to rampant increase in demand for the same in North America due to rising incidence of gastroesophageal reflux disease (GERD) in the region. According to a study conducted by American Gastroenterological Association and published in International Foundation for Functional in February 2016, approximately one-third of the population in U.S. suffers from GERD. According to a study published in National Center for Biotechnology Information (NCBI) in June 2014, the range of GERD prevalence was 18.1%–27.8% in North America, 8.7%–33.1% in the Middle East, 8.8%–25.9% in Europe, 2.5%–7.8% in East Asia, and 11.6% in Australia. Increasing prevalence of GERD creates a favorable environment growth of the antacid medications market.
Increasing self-medication trend driving antacid medications market growth
Increasing inclination of the populace towards self-medication supplemented by growing availability of over-the-counter products in convenient to use sachets is a prevalent trend observed in the market. This trend is expected to continue over the forecast period, in turn fueling market growth.
Global players operating in the antacid medications market
Various companies manufacture antacids and other products for indigestion. Some of these are GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories, and Pfizer, Inc. Sun Pharma launched an ayurvedic digestive remedy called Pepmelt to compete with popular antacids such as Eno (GSK consumer healthcare), Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer). According to 2014 estimates of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 20% of the U.S. population suffered from gastroesophageal reflux disease, or GERD.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/91
- Key players in the market are involved in various business strategies such as product acquisition, in order to expand their product portfolio. For instance, in June 2017, Pfizer India acquired AstraZeneca, a Swedish pharmaceutical firm’s Nekasium, a drug used as antacid. Nekasium was launched in India in 2006 and has been recommended by doctors to reduced hyperacidity.
- Major players in the market are involved in various business strategies such as product launches, in order to expand their product portfolio. For instance, in May 2017, GSK Consumer Healthcare launched ‘ENO Cooling’. It is an antacid sold in powered form in sachets, which offers instant relief against acidity.
- Key players in the market are involved in various business strategies such as product launches, in order to expand their product portfolio and enhance the market presence. For instance, in October 2018, Dr. Reddy’s Laboratories launched ‘Omeprazole’ delayed-release tablets in the U.S. market, which can be used for frequent heartburn issues.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire